Nash, R. A., Bowen, J. D., McSweeney, P. A., Sullivan, K. M., Pavletic, Z. S., Maravilla, K. R., … Kraft, G. H. (2001). Treatment of severe multiple sclerosis (MS) with high-dose immunosuppressive therapy (HDIT) and autologous stem cell transplantation (SCT). BLOOD, 98(11), 687A-687A.

Nash, R. A., J. D. Bowen, P. A. McSweeney, K. M. Sullivan, Z. S. Pavletic, K. R. Maravilla, J. Al-Omaishi, et al. “Treatment of severe multiple sclerosis (MS) with high-dose immunosuppressive therapy (HDIT) and autologous stem cell transplantation (SCT).” BLOOD 98, no. 11 (November 16, 2001): 687A-687A.

Nash RA, Bowen JD, McSweeney PA, Sullivan KM, Pavletic ZS, Maravilla KR, et al. Treatment of severe multiple sclerosis (MS) with high-dose immunosuppressive therapy (HDIT) and autologous stem cell transplantation (SCT). BLOOD. 2001 Nov 16;98(11):687A-687A.

Nash, R. A., et al. “Treatment of severe multiple sclerosis (MS) with high-dose immunosuppressive therapy (HDIT) and autologous stem cell transplantation (SCT).” BLOOD, vol. 98, no. 11, AMER SOC HEMATOLOGY, Nov. 2001, pp. 687A-687A.

Nash RA, Bowen JD, McSweeney PA, Sullivan KM, Pavletic ZS, Maravilla KR, Al-Omaishi J, Corboy JR, Derrington D, DiPersio J, Georges GE, Holmberg LA, LeMaistre CF, Openshaw H, Ryan K, Sunderhaus J, Storek J, Zunt J, Kraft GH. Treatment of severe multiple sclerosis (MS) with high-dose immunosuppressive therapy (HDIT) and autologous stem cell transplantation (SCT). BLOOD. AMER SOC HEMATOLOGY; 2001 Nov 16;98(11):687A-687A.